Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia
This article is protected by copyright. All rights reserved.
Source: International Journal of Cancer - Category: Cancer & Oncology Authors: Eriong Lee ‐Vergés,
Bola S. Hanna,
Haniyeh Yazdanparast,
Vanina Rodríguez,
Marta Leonor Rodríguez,
Ariadna Giró,
Anna Vidal‐Crespo,
Laia Rosich,
Virginia Amador,
Marta Aymerich,
Neus Villamor,
Julio Delgado,
Peter Lichter,
Patricia P Tags: Research Article Source Type: research
More News: Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Clinical Trials | Leukemia | Study | Treanda